Atossa Therapeutics
ATOS
#9791
Rank
HK$0.35 B
Marketcap
HK$41.19
Share price
-4.28%
Change (1 day)
626.13%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.96. In 2024 the company made an earnings per share (EPS) of -HK$1.57 an increase over its 2023 EPS that were of -HK$1.88.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.9524.37%
2024-HK$1.57-16.67%
2023-HK$1.8814.29%
2022-HK$1.6516.67%
2021-HK$1.41-90.86%
2020-HK$15.44-2.96%
2019-HK$15.91-63.09%
2018-HK$43.11-49.63%
2017-HK$85.59-57.87%
2016-HK$203.16-74.01%
2015-HK$781.60-9.18%
2014-HK$860.60-12.86%
2013-HK$987.5770.73%
2012-HK$578.4434.08%
2011-HK$431.42263.47%
2010-HK$118.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29-4,554.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$67.72-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$80.34-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.90 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.65-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA